Metabolic
AOD-9604
AOD-9604 (hGH fragment 176-191)
Also known as hGH 176-191
AOD-9604 corresponds to residues 176-191 of the somatotropin sequence, the C-terminal region studied in early work for activity on adipose tissue in vitro. The research premise is separation of function: retaining lipolytic activity in assays while excluding the IGF-1-mediated signaling of the full-length molecule. Reported results across models have been more modest than preclinical rodent data suggested — a gap worth knowing before designing around it.
Research applications
- Lipolysis and β-adrenergic pathway assays in adipocyte culture
- Comparative studies against full-length hGH
- IGF-1 independence verification studies
Storage
Store lyophilized at -20°C protected from light. Reconstituted at 2-8°C for up to 30 days.
Reconstitution
Reconstitute with bacteriostatic water down the vial wall. Swirl gently.
Published literature
18 papers indexed on PubMed for AOD-9604. Showing 6, reviews first.
- 01Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF et al. · J Am Acad Orthop Surg Glob Res Rev · 2026
- 02Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM · Sports Med · 2026
- 03Human sports drug testing by mass spectrometry
Schänzer W, Thevis M · Mass Spectrom Rev · 2017
- 04Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls
Thevis M, Schänzer W · J Pharm Biomed Anal · 2014
- 05Obesity drugs in clinical development
Halford JC · Curr Opin Investig Drugs · 2006
ReviewPMID 16625817
- 06
Indexed from PubMed, 2026-07-19. We link to sources rather than reproducing them.
Related compounds
Semaglutide
5–20mg · COA published
Long-acting GLP-1 receptor agonist studied extensively for incretin pathway signaling and glucose regulation in preclinical models.
- Purity
- 99.728%
- 9 lab certificates
Tirzepatide
10–30mg · COA published
Dual GIP and GLP-1 receptor agonist — a 39-amino-acid synthetic peptide studied for combined incretin pathway activity.
- Purity
- 99.634%
- 13 lab certificates
Retatrutide
10–30mg · COA published
Triple agonist at GIP, GLP-1, and glucagon receptors — among the most actively studied compounds in current metabolic research.
- Purity
- 99.637%
- 19 lab certificates
Cagrilintide
10mg · COA published
Long-acting amylin analog studied at calcitonin and amylin receptors — a satiety pathway mechanistically distinct from incretin agonism.
- Purity
- 99.939%
- 3 lab certificates
The certificate comes first
Every compound’s independent laboratory analysis is published before you buy, not sent on request.
Verify it without us
Each certificate carries a laboratory key. Enter a batch code and check it at the lab directly.
Ships from Orlando, FL
Orders dispatch within 1 business day of cleared payment, with tracking emailed when the parcel is handed to the carrier. Track any order, account or not.
A person answers
Write to [email protected] and a human replies — no ticket bot, no queue number.
How AOD-9604 compares
Side-by-side against the compounds researchers most often weigh it against, with price per milligram, mechanism and the published certificate for each.
Research goals that include AOD-9604
The research areas this compound is grouped under, each with the other compounds studied alongside it and the published certificates for the group.
AOD-9604
From $44